AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Robbins Arroyo LLP: Amarin Corporation plc (AMRN) Sued for Misleading Shareholders

February 26, 2019

SAN DIEGO & DUBLIN--(BUSINESS WIRE)--Feb 26, 2019--Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Amarin Corporation plc (NasdaqGM: AMRN) filed a class action complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between September 24, 2018 and November 9, 2018. Amarin develops therapeutics for the treatment of cardiovascular diseases in the United States.

View this information on the law firm’s Shareholder Rights Blog: https://www.robbinsarroyo.com/amarin-corp/

Amarin Accused of Misleading Investors About Its Drug Trial

According to the complaint, on September 24, 2018, Amarin issued a press release stating that the company’s REDUCE-IT cardiovascular outcomes study had shown a 25% relative risk reduction for patients taking Vascepa. As a result, Amarin’s securities increased more than 414% that day. Less than two months later, at the Scientific Sessions of the American Heart Association on November 10, 2018, scientists presented the results of the REDUCE-IT trials. The scientists disclosed that the placebo given to the patients may have caused cardiovascular problems in the patients taking it, citing an increase in “bad” LDL cholesterol. As a result, Amarin’s stock price dropped nearly 27% to close at $15.38 per share on November 13, 2018.

Amarin Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leo Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com, or via the shareholder information form on the firm’s website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190226006175/en/

CONTACT: Leo Kandinov

Robbins Arroyo LLP

5040 Shoreham Place

San Diego, CA 92122

LKandinov@robbinsarroyo.com

(619) 525-3990 or Toll Free (800) 350-6003

www.robbinsarroyo.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL

SOURCE: Robbins Arroyo LLP

Copyright Business Wire 2019.

PUB: 02/26/2019 04:08 PM/DISC: 02/26/2019 04:08 PM

http://www.businesswire.com/news/home/20190226006175/en